Eisuke Murakami

9PUBLICATIONS
27CO-AUTHORS
ChemotherapyMedical molecular engineering of nucleic acids and proteinsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 04, 2026
A Study on the Association Between Treatment Response to Atezolizumab Plus Bevacizumab Combination Therapy for Advanced Hepatocellular Carcinoma and Gut Microbiota.

|Oct 29, 2025
Utility of Serum HBV RNA Measurement During Nucleoside/Nucleotide Analog Therapy in Chronic Hepatitis B Patients.

Keiichi Hiraoka, Masataka Tsuge, Michihiko Kawahara

|Nov 27, 2024
Alteration of Gene Expression After Entecavir and Pegylated Interferon Therapy in HBV-Infected Chimeric Mouse Liver.

Huarui Bao, Serami Murakami, Masataka Tsuge

|Oct 26, 2024
Time trend of outcomes according to systemic therapy for patients with unresectable hepatocellular carcinoma: A single-institution study.

Shinsuke Uchikawa, Tomokazu Kawaoka, Serami Murakami

|Aug 17, 2024
Significance of changes in tumor markers in patients treated with durvalumab plus tremelimumab combination therapy as a surrogate marker for tumor response to unresectable hepatocellular carcinoma.

Shinsuke Uchikawa, Tomokazu Kawaoka, Serami Murakami

|May 20, 2024
Deep learning and digital pathology powers prediction of HCC development in steatotic liver disease.

Takuma Nakatsuka, Ryosuke Tateishi, Masaya Sato

Pageof 2

Frequent Collaborators

7 joint publications

Atsushi Ono

6 joint publications

Shinsuke Uchikawa

6 joint publications

Hatsue Fujino

3 joint publications

Masataka Tsuge